Continue to site >
Trending ETFs

Amplify Seymour Cannabis ETF

Active ETF
CNBS
Payout Change
Suspended
Price as of:
$5.49 +0.19 +3.58%
primary theme
Sector Diversified Equity
CNBS (ETF)

Amplify Seymour Cannabis ETF

Payout Change
Suspended
Price as of:
$5.49 +0.19 +3.58%
primary theme
Sector Diversified Equity
CNBS (ETF)

Amplify Seymour Cannabis ETF

Payout Change
Suspended
Price as of:
$5.49 +0.19 +3.58%
primary theme
Sector Diversified Equity

Name

As of 03/26/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Amplify Seymour Cannabis ETF

CNBS | Active ETF

$5.49

$30.9 M

0.00%

$0.00

1.45%

Vitals

YTD Return

28.6%

1 yr return

29.9%

3 Yr Avg Return

-42.3%

5 Yr Avg Return

N/A

Net Assets

$30.9 M

Holdings in Top 10

46.2%

52 WEEK LOW AND HIGH

$5.3
$3.43
$5.75

Expenses

OPERATING FEES

Expense Ratio 1.45%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 124.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 03/26/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Amplify Seymour Cannabis ETF

CNBS | Active ETF

$5.49

$30.9 M

0.00%

$0.00

1.45%

CNBS - Profile

Distributions

  • YTD Total Return 28.6%
  • 3 Yr Annualized Total Return -42.3%
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.05%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Amplify Seymour Cannabis ETF
  • Fund Family Name
    Amplify ETFs
  • Inception Date
    Jul 22, 2019
  • Shares Outstanding
    6200000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Dustin Lewellyn

Fund Description

Under normal market conditions, the Fund seeks to achieve its investment objective by investing in the securities of companies engaged in cannabis and hemp-related activities selected by the Fund’s investment adviser, Amplify Investments LLC (“Amplify Investments” or the “Adviser”). Pursuant to this strategy, the Fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. Penserra Capital Management LLC (“Penserra”) and Seymour Asset Management LLC (“Seymour”, and collectively with Penserra, the “Sub-Advisers”) serve as the investment sub-advisers to the Fund. Penserra is responsible for executing and implementing the Adviser’s decisions and constructing the Fund’s portfolio.

The Fund is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications, which includes: 

Cannabis/Hemp Plant (Pharmaceuticals/Biotechnology, Cultivation & Retail, Hemp Products and Cannabis-Infused Products)
Support (Agricultural Technology, Real Estate and Commercial Services)
Ancillary (Consumption Devices/Mechanisms, Investing & Finance, Technology & Media and Other Ancillary)

The Fund’s portfolio manager, Tim Seymour, will actively seek investment opportunities in companies fitting within one of these classifications through the use of information available in public regulatory filings, third-party research, meetings with company management, and other publicly available information. Through portfolio management, the Fund’s portfolio manager will seek opportunities to make allocations among the classifications and the sub-classifications and to take advantage of market pricing dislocations. In addition, the Fund’s portfolio manager will conduct an on-going fundamental analysis of individual companies, which includes top-down and bottom-up factors. Top-down factors considered include regulatory changes, macro-economic data and political events. Bottom-up factors considered include company growth rates relative to its peer group, income statement, free cash flow, balance sheet strength, management quality, environmental, social, and governance scoring and strategic partnerships. The Fund’s portfolio manager believes that this fundamental approach will allow for adjustments in the Fund’s portfolio to address the dynamic pace of evolution for cannabis and hemp-related companies.

The Fund will primarily invest in equity securities and derivative instruments intended to provide exposure to companies principally engaging in the cannabis and hemp ecosystem. As part of this strategy, the derivative instruments may include, but are not limited to, total return swaps. For purposes of the Fund’s 80% investment policy, for any derivative instruments the assets will be valued on a mark-to-market basis.

In order to be eligible for investment in the Fund’s portfolio, securities must have adequate constituent liquidity and accessibility for an exchange-listed product, as determined by the Adviser. In addition, under normal market circumstances, the Fund’s direct investment in equity securities must comply with the following:

a security must be listed on a regulated, major stock exchange in the form of shares tradeable for non-U.S. investors without restrictions;
for U.S. based equity securities, 90% of the U.S. based equity weight must be in companies with a market capitalization of at least $75,000,000; and a non-U.S. equity security must have a market capitalization of at least $100,000,000; and
for U.S. based equity securities, at least 70% of the equity weight must have either: (i) a monthly trading volume of at least 250,000, or (ii) an average notional value of monthly trades of at least $25,000,000 over the prior six months; and all non-U.S. equity securities must have either: (i) a monthly trading volume of at least 250,000, or (ii) an average notional value of monthly trades of at least $25,000,000 over the prior six months.

The Fund will only directly invest in companies that engage in activities that are legal in the country where it is incorporated, as well as in the country or countries where its operations are conducted. The Fund will not hold direct ownership in any companies that engage in cannabis-related business unless permitted by national and local laws of the relevant jurisdiction, including United States (“U.S.”) federal and state laws. Because the Fund only directly holds securities from companies that are currently engaged exclusively in legal activities under national and local laws, the Fund will not include equity securities of any company that engages in the cultivation, production or distribution of marijuana or products derived from marijuana for medical or non-medical purposes in a particular country, including the U.S., unless and until such time as the cultivation, production or distribution of such medical or non-medical marijuana, as applicable, becomes legal under local and national laws governing the company in such country. As of the date of this prospectus, the Fund does not directly invest in companies that grow or distribute marijuana inside of the U.S. or any “medical marijuana” companies in the United States. Any pharmaceutical companies held by the Fund would have the necessary permits and licenses to engage in lawful medical research using cannabinoids to produce government approved drugs, or to otherwise produce, market or distribute such drugs. This activity is distinct from the “medical marijuana” business, which refers to the use of the cannabis leaf, as opposed to specific extracts in pharmaceutical form, to alleviate the symptoms of injury or illness. If U.S. federal law changes in the future and these cannabis-related business activities become legal at the federal level, the Fund may begin directly investing in U.S. listed companies in the cannabis and hemp ecosystem in accordance with the Fund’s investment objective and principal investment strategy. The Fund may indirectly obtain exposure to such companies through its use of derivative instruments, as described above.

The Fund’s portfolio manager expects, under normal market circumstances, that the Fund’s portfolio will consist of 20 to 45 companies. These securities may be issued by small, medium and large capitalization companies operating in both emerging and developed market countries. The Fund may also invest in securities of real estate investment trusts. The Fund may purchase equity securities that trade on U.S. or non-U.S. securities exchanges and in the securities of non-U.S. companies that utilize American Depositary Receipts (“ADRs”) or Global Depositary Receipts (“GDRs”) to list on certain exchanges. To the extent that the security of a non-U.S. issuer is available as an ADR, the Fund will purchase the ADR, provided that the ADR’s liquidity is comparable to that of the issuer’s equity security. As of the date of this Prospectus, the Fund invests in securities that are primarily listed on the following exchanges: New York Stock Exchange (“NYSE”), NYSE American, Nasdaq Stock Market, TSX Exchange, TSX Venture Exchange, Australian Securities Exchange and the Tel Aviv Stock Exchange. The Fund may, in the future, invest in companies primarily listed on additional exchanges to the extent that such companies are in compliance with the above-referenced investment and legal requirements. Further, the Fund may utilize derivatives instruments that are available over-the-counter (“OTC”) rather than exchange-traded.

The Fund will seek to lend portfolio securities in an amount up to one-third of its total assets to brokers, dealers and other financial institutions. In a portfolio securities lending transaction, the Fund receives from the borrower an amount equal to the interest paid or the dividends declared on the loaned securities during the term of the loan as well as the interest on the collateral securities, less any fees (such as finders or administrative fees) the Fund pays in arranging the loan.

The Fund may pursue its investment objective by investing in an affiliated series of Amplify ETF Trust, the Amplify U.S. Alternative Harvest ETF. Amplify Investments LLC, investment adviser to the Fund, serves as the investment adviser to the Amplify U.S. Alternative Harvest ETF.

Diversification Status. The Fund is classified as “non-diversified” under the Investment Company Act of 1940, as amended (the “1940 Act”).

Read More

CNBS - Performance

Return Ranking - Trailing

Period CNBS Return Category Return Low Category Return High Rank in Category (%)
YTD 28.6% -22.6% 100.1% 23.33%
1 Yr 29.9% -40.9% 71.4% 30.00%
3 Yr -42.3%* -43.3% 16.0% 93.10%
5 Yr N/A* -5.7% 22.8% 64.71%
10 Yr N/A* -2.2% 13.3% 44.83%

* Annualized

Return Ranking - Calendar

Period CNBS Return Category Return Low Category Return High Rank in Category (%)
2023 -16.1% -34.8% 38.7% 80.00%
2022 -64.0% -72.7% 8.2% 90.00%
2021 -19.0% -31.7% 27.4% 72.41%
2020 31.2% -29.0% 233.6% 71.43%
2019 N/A -2.0% 66.0% N/A

Total Return Ranking - Trailing

Period CNBS Return Category Return Low Category Return High Rank in Category (%)
YTD 28.6% -22.6% 100.1% 23.33%
1 Yr 29.9% -40.9% 71.4% 30.00%
3 Yr -42.3%* -43.3% 16.0% 93.10%
5 Yr N/A* -5.7% 22.8% N/A
10 Yr N/A* -2.2% 13.3% N/A

* Annualized

Total Return Ranking - Calendar

Period CNBS Return Category Return Low Category Return High Rank in Category (%)
2023 -16.1% -33.0% 39.0% 83.33%
2022 -64.0% -72.7% 8.2% 90.00%
2021 -19.0% -31.7% 28.3% 72.41%
2020 32.0% -28.9% 233.9% 71.43%
2019 N/A 0.4% 66.5% N/A

CNBS - Holdings

Concentration Analysis

CNBS Category Low Category High CNBS % Rank
Net Assets 30.9 M 3.44 M 31.2 B 85.71%
Number of Holdings 35 20 389 80.00%
Net Assets in Top 10 10.9 M 2.2 M 5.86 B 88.57%
Weighting of Top 10 46.17% 17.1% 91.3% 68.57%

Top 10 Holdings

  1. Tilray Brands Inc 8.92%
  2. First American Government Obligations Fund 6.17%
  3. WM Technology Inc 5.61%
  4. Innovative Industrial Properties Inc 4.85%
  5. TerrAscend Corp 4.73%
  6. Cronos Group Inc 4.57%
  7. GrowGeneration Corp 4.46%
  8. Silver Spike Investment Corp 3.26%
  9. SNDL Inc 1.82%
  10. Village Farms International Inc 1.77%

Asset Allocation

Weighting Return Low Return High CNBS % Rank
Cash
67.02% 0.00% 93.41% 5.71%
Stocks
45.20% 0.00% 99.96% 65.71%
Preferred Stocks
0.00% 0.00% 41.72% 42.86%
Convertible Bonds
0.00% 0.00% 3.05% 29.41%
Bonds
0.00% 0.00% 94.79% 31.43%
Other
-12.22% -12.22% 91.95% 100.00%

Stock Sector Breakdown

Weighting Return Low Return High CNBS % Rank
Healthcare
56.08% 0.00% 65.82% 11.54%
Technology
17.12% 0.00% 72.56% 61.54%
Real Estate
8.90% 0.00% 16.54% 7.69%
Consumer Defense
8.20% 0.00% 50.44% 19.23%
Consumer Cyclical
6.07% 0.00% 34.19% 46.15%
Industrials
3.62% 0.00% 90.47% 69.23%
Utilities
0.00% 0.00% 85.14% 53.85%
Financial Services
0.00% 0.00% 95.51% 50.00%
Energy
0.00% 0.00% 32.10% 42.31%
Communication Services
0.00% 0.00% 16.38% 30.77%
Basic Materials
0.00% 0.00% 17.92% 84.62%

Stock Geographic Breakdown

Weighting Return Low Return High CNBS % Rank
US
38.50% 0.00% 99.90% 74.29%
Non US
6.70% 0.00% 83.83% 57.14%

CNBS - Expenses

Operational Fees

CNBS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.45% 0.41% 5.61% 34.29%
Management Fee 0.65% 0.25% 1.90% 54.29%
12b-1 Fee 0.00% 0.00% 1.00% 8.33%
Administrative Fee N/A 0.03% 0.19% N/A

Sales Fees

CNBS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 4.25% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

CNBS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 2.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

CNBS Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 124.00% 0.00% 124.00% 100.00%

CNBS - Distributions

Dividend Yield Analysis

CNBS Category Low Category High CNBS % Rank
Dividend Yield 0.00% 0.00% 14.04% 77.14%

Dividend Distribution Analysis

CNBS Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annually Quarterly Quarterly

Net Income Ratio Analysis

CNBS Category Low Category High CNBS % Rank
Net Income Ratio 0.05% -2.66% 5.19% 54.29%

Capital Gain Distribution Analysis

CNBS Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

CNBS - Fund Manager Analysis

Managers

Dustin Lewellyn


Start Date

Tenure

Tenure Rank

Jul 15, 2019

2.88

2.9%

Dustin Lewellyn, CFA. Mr. Lewellyn has extensive background in institutional investment process with a specific focus on exchange-traded funds (“ETFs”). Mr. Lewellyn was a portfolio manager at BGI (now part of Blackrock), and he managed a number of international equity funds. Dustin also was head of ETF product management and product development at Northern Trust where he oversaw the build out and management of all areas of a new ETF business, including primary responsibility for the portfolio management process surrounding the ETFs. Mr. Lewellyn also built and ran a new ETF business for Charles Schwab, including having primary responsibility for the technology and investment process to support portfolio management for the ETFs. Mr. Lewellyn started a consulting business with a focus on ETFs and helped numerous new ETF sponsors, as well as service providers, understand the resource requirements to participate in the industry utilizing current best practices. Mr. Lewellyn holds a B.A. from University of Iowa and is a CFA Charterholder. He also holds security licenses 7, 63, 66 and 24.

Ernesto Tong


Start Date

Tenure

Tenure Rank

Jul 15, 2019

2.88

2.9%

Mr. Tong has been a managing director with Penserra since 2015. Prior to joining Penserra, Mr. Tong spent seven years as a vice president at Blackrock, where he was a portfolio manager for a number of the iShares ETFs, and prior to that, he spent two years in the firm’s index research group.

Anand Desai


Start Date

Tenure

Tenure Rank

Jul 15, 2019

2.88

2.9%

Anand Desai. Mr. Desai has been an Associate with Penserra since 2015. Prior to joining the Penserra Capital Management, LLC, Mr. Desai was a portfolio fund accountant at State Street for five years.

Timothy Seymour


Start Date

Tenure

Tenure Rank

Jul 15, 2019

2.88

2.9%

Mr. Seymour is a portfolio manager at Amplify Investments. Mr. Seymour has over 20 years of investment experience as a portfolio manager, allocator, and capital markets professional across multiple asset classes. Mr. Seymour has been an early stage investor in the cannabis industry and serves as a board member or in an advisory role for several private cannabis companies. In addition, Mr. Seymour is a frequent and long-time contributor on CNBC, including over a decade of appearances on the show “Fast Money.” Mr. Seymour is the founder and Chief Investment Officer of Seymour Asset Management (“SAM”). SAM provides both asset management and wealth management services for its clients, including direct investment and allocation to private equity and alternative assets. Prior to SAM, Mr. Seymour was the Chief Investment Officer and co-founder of Triogem Asset Management (“Triogem”), where he helped run the firm’s flagship fund, a long/short fund with an emphasis on global emerging markets. Triogem’s investment approach was rooted in running a low volatility portfolio that managed top down risks while employing a rigorous research process to bottom up stock picking.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.75 23.1 8.85 1.25